Imunon, Inc. Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value
Imunon, Inc. (IMNN) had Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value of $8.04 million as of 2012-12-31, per its 10-K filed 2014-03-13.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue · last filed 2014-03-13
- 2012-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $8.04M.
- 2012-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $14.23M.
- 2012-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $12.29M.
- 2011-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value $10.16M; Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value as first filed $10.40M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value as first filed |
|---|---|---|
| 2012-12-31 | $8.04M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $14.23M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $12.29M 10-Q · filed 2012-08-14 | |
| 2011-12-31 | $10.16M 10-K · filed 2013-03-18 | $10.40M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |